VVUS Related Upgrades

Aug 7, 2012 06:41 AM Lazard Capital Upgrades Vivus (VVUS) to Buy

Jul 18, 2012 07:10 AM Jefferies Upgrades Vivus (VVUS) to Hold

Jun 28, 2012 03:39 PM UPDATE: JPMorgan Upgrades Orexigen Therapeutics (OREX) to Overweight, Best Opportunity in Obesity Space

Mar 30, 2012 07:05 AM Brean Murray Carret & Co. Upgrades Vivus (VVUS) to Buy After FDA's Cardiovascular Advisory Panel Meeting

Feb 23, 2012 09:09 AM Rodman & Renshaw Upgrades Vivus (VVUS) to Market Outperform

Feb 23, 2012 09:05 AM Leerink Swann Upgrades Vivus (VVUS) to Outperform; Becoming A More Attractive Asset For Big Pharma After Qnexa Approval

Feb 23, 2012 07:59 AM Brean Murray Carret & Co. Upgrades Vivus (VVUS) to Hold; Removed From N-T Conviction List as Large Panel Vote Surprises

Dec 8, 2010 06:59 AM BofA/Merrill Lynch Upgrades Vivus (VVUS) Two-Notches to Buy

Oct 29, 2010 07:07 AM JP Morgan Upgrades VIVUS Inc. (VVUS) to Overweight

Sep 22, 2010 12:34 PM VIVUS (VVUS) Is Today's Top Performing Wall Street Upgrade

Sep 22, 2010 08:28 AM Vivus (VVUS) Higher On Canaccord Genuity Upgrade to Buy

Jul 16, 2010 08:10 AM J.P. Morgan on Biotechnology and Drugs Stocks; Upgrades ARNA, Cuts VVUS

Jul 14, 2010 07:37 AM Leerink Swann Upgrades Vivus Inc. (VVUS) to Outperform; Qnexa Panel Documents Not Too Worrisome

Dec 3, 2008 10:01 AM Matrix Lighthouse Rating Changes 12/03

May 21, 2008 11:56 AM Canaccord Upgrades Vivus (VVUS) to Buy

May 7, 2008 10:29 AM Matrix USA Rating Changes 5/7

Nov 14, 2007 09:07 AM Matrix USA Rating Changes 11/14

Apr 26, 2005 07:38 AM RBC Capital Markets Upgrades VVUS